You are here :
SYGNIS Pharma AG
> Sitemap
deutsch
| english
Company
Amnestix
CNS Program
Investor Relations
News and Media
Contact
Stockquote
Sitemap
SYGNIS Pharma AG
The Company
History
Strategy
Executive Committee
Supervisory Board
Advisory Board
Scientific Advisory Board
Clinical Advisory Board
Amnestix Inc.
CNS Program
Clinical Trials
AXIS 2
AXIS 1
Pipeline
AX200
AX200 in Acute Stroke
AX200 in Recovery from Stroke
AX200 in ALS
AX200 in SCI
AX200 in PAO
KIBRA Modulators
SY300
Indications
Stroke
Cognitive Dysfunction/ Dementia
ALS
Spinal cord injury
Discovery Platforms
Neural Stem Cell Differentiators
Publications
Investor Relations
Stock
Stockquotes
Shareholder Structure
Mandatory Offer
Prospectus 2008 for capital increases
Key Figures
Financial Reports
Fiscal Year 2011
Fiscal Year 2010
Fiscal Year 2009
Fiscal Year 2008
Annual Document
Corporate Governance
Corporate Governance Declaration
Declaration of Conformity
Code of Ethics
Compensation of Boards
Directors Dealings
Risk management at SYGNIS Pharma AG
Annual General Meeting
Annual General Meeting 2010
Annual General Meeting 2009
Annual General Meeting 2008
Financial Schedule
Ad Hoc Releases
Analysts Coverage
Contact and Information
Global Investor Contact
News and Media
Press Releases
Press Releases 2010
Press Releases 2009
Press Kit
SYGNIS in the Media
Pictures
Events
Contact
Contact
Imprint
Contact Form
Map
Print
Imprint
Disclaimer
Sitemap
© 2010 SYGNIS AG